Tibet Rhodiola Pharmaceutical Holding Co. (600211.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 35.85

From 52W high−32.38%

Volume1.61M

Market capCNY 12.30B

P/E (TTM)13.1x

P/S (TTM)3.9x

Div yield5.59%

Key dataSep 18, 2026

Open

CNY 35.85

From 52W high

−32.38%

Volume

1.61M

Market cap

CNY 12.30B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

9.1x

P/E (TTM)

13.1x

RSI (14)

37.7

MomentumView details →

1D Return

−2.13%

YTD Return

−15.04%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

13.1x

EV/EBITDA

9.1x

EV/Sales

3.4x

P/S (TTM)

3.9x

P/B (TTM)

3.1x

ProfitabilityView details →

Gross Margin

93.77%

Net Margin

32.32%

EBITDA Margin

37.56%

ROE (TTM)

24.80%

ROA (TTM)

15.13%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

+6.34%

EPS YoY

−3.99%

FCF YoY

+28.58%

Revenue CAGR 3Y

+5.29%

EPS CAGR 3Y

+25.00%

EBITDA YoY

—

MomentumView details →

1D Return

−2.13%

YTD Return

−15.04%

1Y Return

−29.83%

RSI (14)

37.7

vs 50D SMA

−6.10%

vs 200D SMA

−10.77%

Capital & dividendView details →

Debt/Equity

0.27x

Current Ratio

2.88x

Quick Ratio

2.77x

Div Yield

5.59%

Div Rate

CNY 2.02

Div Growth 1Y

+21.98%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.99B

Net Income (TTM)

967.36M

Op. CF (TTM)

1.08B

Latest newsMore news →

Tibet Rhodiola Pharmaceutical announced a differentiated interim dividend for H1 2026, paying 1.146 yuan per share (tax included) based on 322 million total shares minus 4.0001 million shares in the buyback account, totaling 365 million yuan, representing 60% of half-year net profit attributable to shareholders.15d ago

Tibet Pharmaceutical announced that as of the end of August 2026, it had repurchased 4,000,058 shares of its own stock, representing 1.24% of total shares, for a total amount of 177,595,651.46 yuan.20d ago

Similar companies

老百姓603883.SH 康美药业600518.SH 奥锐特605116.SH 键凯科技688356.SH 技源集团603262.SH 益丰药房603939.SH Find similar companies →

Latest newsMore news →

Tibet Rhodiola Pharmaceutical announced a differentiated interim dividend for H1 2026, paying 1.146 yuan per share (tax included) based on 322 million total shares minus 4.0001 million shares in the buyback account, totaling 365 million yuan, representing 60% of half-year net profit attributable to shareholders.15d ago Tibet Pharmaceutical announced that as of the end of August 2026, it had repurchased 4,000,058 shares of its own stock, representing 1.24% of total shares, for a total amount of 177,595,651.46 yuan.20d ago Tibet Rhodiola Pharmaceutical proposed a cash dividend of 1.15 yuan per share (pre-tax) to all shareholders, based on total share capital excluding treasury shares.39d ago